Capio’s application for de-listing approved
Capio AB (publ) (“Capio”) has, as previously announced, applied for de-listing of Capio’s shares from Nasdaq Stockholm. Nasdaq Stockholm has now approved the application and decided that the last day of trading will be 28 November 2018.
For information, please contact:
Henrik Brehmer, SVP Group Communication & Public Affairs
Telephone: +46 761 11 34 14
Capio AB (publ) is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. Capio operates in five countries; Sweden, Norway, Denmark, France and Germany. In 2017, Capio’s 13,314 employees (average full-time equivalents) provided healthcare services during 5.1 million patient visits across the Group’s facilities, generating net sales of MSEK 15,327. Capio operates across three geographic segments: Nordic (57% of Group net sales 2017), France (35% of Group net sales 2017) and Germany (8% of Group net sales 2017). For more information about Capio, please see www.capio.com.